Education
About Us
Working with TipRanks
Follow Us
Cytokinetics (CYTK)
NASDAQ:CYTK
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 18.47M | $ 7.53M | $ 94.59M | $ 70.43M | $ 55.83M |
| Gross Profit | $ 18.47M | $ -322.59M | $ -146.22M | $ -89.51M | $ -41.12M |
| Operating Income | $ -536.25M | $ -496.20M | $ -324.20M | $ -186.31M | $ -93.94M |
| EBITDA | $ -493.48M | $ -456.68M | $ -329.40M | $ -176.34M | $ -86.78M |
| Net Income | $ -589.53M | $ -526.24M | $ -402.55M | $ -242.37M | $ -164.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.08B | $ 614.82M | $ 782.58M | $ 471.64M | $ 464.06M |
| Total Assets | $ 1.40B | $ 824.32M | $ 1.01B | $ 841.32M | $ 533.80M |
| Total Debt | $ 695.45M | $ 755.77M | $ 749.34M | $ 269.93M | $ 138.94M |
| Net Debt | $ 600.59M | $ 642.75M | $ 683.76M | $ 157.26M | $ 55.95M |
| Total Liabilities | $ 1.54B | $ 1.21B | $ 1.12B | $ 597.46M | $ 420.42M |
| Stockholders' Equity | $ -135.37M | $ -386.32M | $ -107.90M | $ 243.86M | $ 113.38M |
| Cash Flow | |||||
| Free Cash Flow | $ -399.80M | $ -415.75M | $ -310.85M | $ -191.39M | $ -2.11M |
| Operating Cash Flow | $ -395.89M | $ -414.33M | $ -299.52M | $ -142.52M | $ 8.94M |
| Investing Cash Flow | $ -553.10M | $ 239.25M | $ -262.13M | $ -147.78M | $ -196.51M |
| Financing Cash Flow | $ 930.61M | $ 221.32M | $ 516.17M | $ 319.98M | $ 234.12M |